Syndax Pharmaceuticals Inc SEC filings SNDX
Syndax Pharmaceuticals Inc has 657 filings in SEC EDGAR's recent list, going back to Apr 6, 2007. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 2, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Dec 7, 2023 | — |
| CORRESP | Letter to the SEC | Nov 28, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 13, 2023 | — |
| RW | Filing | Mar 24, 2021 | — |
| EFFECT | Filing | Sep 10, 2019 | — |
| CORRESP | Letter to the SEC | Sep 6, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 5, 2019 | — |
| CT ORDER | Filing | Mar 28, 2019 | — |
| CT ORDER | Filing | Dec 20, 2018 | — |
| CT ORDER | Filing | Nov 27, 2018 | — |
| CT ORDER | Filing | Aug 29, 2018 | — |
| CT ORDER | Filing | Jun 13, 2018 | — |
| CT ORDER | Filing | Apr 3, 2018 | — |
| CT ORDER | Filing | Sep 26, 2017 | — |
| CT ORDER | Filing | May 23, 2017 | — |
| EFFECT | Filing | Apr 20, 2017 | — |
| CORRESP | Letter to the SEC | Apr 14, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2017 | — |
| CT ORDER | Filing | Dec 9, 2016 | — |
| CT ORDER | Filing | Oct 6, 2016 | — |
| CT ORDER | Filing | Mar 7, 2016 | — |
| CERTNAS | Auto-generated paper document | Mar 3, 2016 | — |
| EFFECT | Filing | Mar 2, 2016 | — |
| 8-A12B | Form 8-a12b | Mar 2, 2016 | — |
| CORRESP | Letter to the SEC | Feb 29, 2016 | — |
| CORRESP | Letter to the SEC | Feb 29, 2016 | — |
| CORRESP | Letter to the SEC | Feb 10, 2016 | — |
| UPLOAD | Letter from the SEC | Jan 14, 2016 | — |
| CORRESP | Letter to the SEC | Jan 12, 2016 | — |
| DRS/A | Filing | Nov 16, 2015 | — |
| DRSLTR | Filing | Nov 12, 2015 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2015 | — |
| DRSLTR | Filing | Oct 19, 2015 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2015 | — |
| DRS/A | Filing | Oct 2, 2015 | — |
| DRSLTR | Filing | Oct 1, 2015 | — |
| UPLOAD | Letter from the SEC | Sep 22, 2015 | — |
| D | Filing | Aug 28, 2015 | — |
| DRS | Filing | Aug 25, 2015 | — |
| D | Filing | Jun 15, 2015 | — |
| RW | Filing | Jan 22, 2015 | — |
| D | Filing | Sep 19, 2014 | — |
| DRS/A | Filing | Mar 3, 2014 | — |
| D | Filing | Feb 13, 2014 | — |
| D | Filing | Feb 13, 2014 | — |
| DRS/A | Filing | Jan 31, 2014 | — |
| DRS/A | Filing | Dec 23, 2013 | — |
| DRS/A | Filing | Nov 22, 2013 | — |
| DRS | Filing | Nov 15, 2013 | — |
| D | Filing | Nov 14, 2013 | — |
| D | Filing | Aug 30, 2013 | — |
| D | Filing | Aug 5, 2010 | — |
| D | Filing | Feb 3, 2010 | — |
| REGDEX | Auto-generated paper document | Apr 6, 2007 | — |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SNDX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1395937
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.